A 58-year-old man with COPD and type 2 diabetes presents with a 5-day history of productive cough, fever (39.2°C), and dyspnea. Chest X-ray shows a left lower lobe infiltrate. Sputum culture is pending. He has a documented penicillin allergy (rash at age 10). Which beta-lactam antibiotic is the safest option for presumed community-acquired pneumonia?

Explanation

## Clinical Context The patient has community-acquired pneumonia (CAP) with COPD and diabetes as comorbidities. A penicillin allergy is documented, but the nature of the reaction (rash at age 10) suggests a low-risk, non-IgE-mediated reaction with negligible risk of severe cross-reactivity with cephalosporins. ## Penicillin Allergy and Cephalosporin Cross-Reactivity **Key Point:** The cross-reactivity rate between penicillins and third-generation cephalosporins is approximately 0.1–1%. A non-anaphylactic reaction (rash) in childhood carries negligible risk of severe cephalosporin allergy. Amoxicillin-clavulanate (Option B) and Piperacillin-tazobactam (Option D) are penicillin-based antibiotics and are contraindicated in a patient with a documented penicillin allergy. **High-Yield:** Third-generation cephalosporins (ceftriaxone, cefotaxime) are safe and preferred in patients with a history of non-IgE-mediated penicillin reactions (rash, delayed reactions). Anaphylaxis or Stevens-Johnson syndrome would warrant avoidance of all beta-lactams. ## Why Ceftriaxone is the Best Answer Both ceftriaxone and cefotaxime are third-generation cephalosporins with equivalent safety profiles in penicillin-allergic patients and equivalent coverage for CAP pathogens. However, **ceftriaxone (1–2 g IV/IM once daily)** is the preferred and most widely cited agent in international CAP guidelines (IDSA/ATS, BTS) for hospitalized patients, including those with penicillin allergy (non-anaphylactic). Its once-daily dosing offers a practical advantage over cefotaxime (which requires dosing every 8–12 hours), making it the standard of care in clinical practice. **Clinical Pearl (Harrison's Principles of Internal Medicine):** For hospitalized non-ICU CAP, the recommended regimen is a beta-lactam (ceftriaxone preferred) plus a macrolide, or a respiratory fluoroquinolone alone. Ceftriaxone is the default beta-lactam in this setting. ## Cephalosporin Safety in Penicillin Allergy | Penicillin Reaction Type | Severity | Cephalosporin Risk | Recommendation | |--------------------------|----------|-------------------|----------------| | Rash (non-IgE mediated) | Low | 0.1–1% | **Safe to use third-generation** | | Delayed reaction (>72 hrs) | Low | <1% | Safe to use | | Anaphylaxis | High | 1–3% | Avoid; use fluoroquinolone or macrolide | | Stevens-Johnson / TEN | High | Avoid | Use non-beta-lactam | **Why not the other options?** - **B (Amoxicillin-clavulanate):** A penicillin — directly contraindicated in documented penicillin allergy. - **C (Cefotaxime):** Equally safe and effective, but requires more frequent dosing (q8–12h) and is not the first-line agent cited in major CAP guidelines compared to ceftriaxone. - **D (Piperacillin-tazobactam):** A penicillin — directly contraindicated in documented penicillin allergy. **Mnemonic:** **SAFE-C** = **S**evere reaction → avoid all beta-lactams; **A**naphylaxis → avoid; **F**luoroquinolone as alternative; **E**arly/mild rash → cephalosporin safe; **C**eftriaxone = preferred 3rd-gen for CAP.